RESULTS	However , between weeks 3 and 40 after vaccination , S. aureus bacteremia developed in 11 of 892 patients in the vaccine group who could be evaluated for bacteremia , as compared with 26 of 906 patients in the control group ( estimate of efficacy , 57 percent ; 95 percent confidence interval , 10 to 81 percent ; nominal P = 0.02 ) .\